Authors
Latest:
Understand the Impact of the ACA on Women’s Equity and Accessible ContraceptivesAccess to birth control is a crucial part of preventive health care, but financial barriers persist
Latest:
Advice for Optimizing Treatment Success in CLLExperts share final thoughts and advice for clinicians in the community to help optimize treatment success in CLL.
Latest:
The European Medicines Agency: A Modern Robin Hood?Many studies with a stated goal of advancing child health care in administratively-defined minors have no clinical value and may even harm young patients.
Latest:
Two Laws Expand Protections for Nursing EmployeesCreating additional space for nursing mothers can be challenging in small pharmacies
Latest:
RSV Vaccines See a Pricey Leap Forward in Disease PreventionOlder adults without a Part D plan face costs ranging from $180 to $295 per shot.
Latest:
From Shelf to System: Enhancing Digital Visibility in Medication InventoryHealth care automation enhances efficiency, yet medication inventory visibility remains a challenge.
Latest:
Establishing Specialty Pharmacy Beyond US Borders: Opportunities and ChallengesThe 5 largest specialty therapeutic groups—oncology, autoimmune, immunology, HIV, and multiple sclerosis—will account for 74% of specialty spending growth over the next five years.
Latest:
Affordability of Orphan Drugs Hinges on Global CollaborationCross-border collaborations are the way forward to make life-saving treatments more affordable and accessible to patients with rare diseases around the world.
Latest:
Potential for Precision: Exploring Targeted Therapies in mCRC CarePanelists discuss how the importance of having pharmacists embedded in oncology clinics has transformed metastatic colorectal cancer care by enabling real-time decision-making and dose adjustments, while highlighting that these are exciting times with multiple new oral treatment options that patients often prefer over infusions, though managing adherence and side effects remains challenging, and emphasizing that current targeted therapy opportunities include rare but actionable NTRK fusions, HER2 amplifications (3% of cases with multiple treatment options), and KRAS G12C mutations (3% of cases), with future promise in pan-RAS inhibitors, expanded immunotherapy beyond MSI-high tumors, and combination therapies, though dermatologic toxicity from targeted agents like RAS inhibitors will likely be the rate-limiting factor requiring better assessment tools and multidisciplinary management including dermatology support.
Latest:
Global Patient Registries Can Advance Opportunities for Rare Disease ResearchCollaboration and knowledge sharing amongst rare disease researchers can be difficult, as these researchers are often spread out throughout the world.
Latest:
Motivational Interviewing to Conquer Barriers for Diabetes ManagementMotivational interviewing serves as a beneficial strategy to enhance medication adherence and improve patient outcomes in diabetes management.
Latest:
Optimizing Self-Management for Outpatient Pharmacy Patients With DiabetesThe use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Latest:
The Role of Physical Activity in Breast Cancer Risk Reduction and SurvivalPharmacists can educate patients on nonpharmacologic strategies that help improve survival outcomes.
Latest:
New Therapeutics Treat Homologous Recombination Repair DeficiencyUnderstanding causes, consequences proves vital to develop therapies that exploit vulnerabilities of the cancer cells.
Latest:
Wearable Wrist Monitoring Devices Can Improve Atrial Fibrillation OutcomesThe use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.
Latest:
Pharmacists Can Apply Their Expertise to the Medical Psilocybin ActEngagement and recognition of pharmacist expertise grows as state psychedelic bills expand.
Latest:
APhA 2025: Nakia Eldridge, PharmD, MBA, Highlights Must-See SessionsNakia Eldridge, PharmD, MBA, shares insights for health system and community pharmacists attending the 2025 APhA Annual Meeting & Exposition.
Latest:
Equitable Representation in Triple-Negative Breast Cancer Clinical TrialsBlack women have higher rates of triple-negative breast cancer (TNBC) incidence and mortality than the general US population. Despite this, they are underrepresented in TNBC clinical trials.
Latest:
A New Frontier in the Fight Against Rare DiseaseRare disease specialty pharmacies offer customizable pharmacy and patient services to make it easier for people living with rare, complex, and often isolating conditions to access the therapy, care, and resources they need.
Latest:
Developing and Implementing Immunization Standing Orders and ProtocolsVaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.
Latest:
Actionable Mutations in Hematologic MalignanciesThe use of high throughput technologies has revolutionized the understanding of the cancer genome.
Latest:
Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional CareStudents are being exposed to new patient experiences through collaboration with practitioners.
Latest:
Focus on Multiple Sclerosis: Benefits of Advanced Pharmacist Certification, a Glimpse into the Drug PipelinePharmacists who educate patients with multiple sclerosis and expand their understanding and knowledge of the condition empowers them to take part in a more active role in managing their health.
Latest:
Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health OutcomesAdditional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.
Latest:
Navigating the Fellowship Journey: A Road Map to SuccessThe process teaches resilience, adaptability, and self-awareness.
